Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS))
Completed · Phase 4 · Has a placebo group
Conditions studied: Healthy, Attention Deficit Hyperactivity Disorder
In brief
The goal of this research is to understand the functioning of 'regulatory circuits' in the brain. We are also interested in how the medications methylphenidate and naltrexone affect these regulatory circuits. This research study will use a scanning technique known as functional magnetic resonance imaging (fMRI) which takes a special kind of picture of the brain that enables us to "see the brain at work". Adult participants will be given a one-time dose of either methylphenidate, naltrexone,or placebo before each fMRI scan session. The main purpose for this research is to better understand the functioning of regulatory circuits in healthy individuals and individuals with psychiatric disorders. This research may one day help us develop better treatments for these disorders.
Key facts
- Study ID
- NCT01993108
- Run by
- University of Michigan
- People needed
- 23
- Starts
- 2013-10-01
- Expected to finish
- 2017-02-01
- Last updated by the study team
- 2018-06-18
Who can join
Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.
Where it is running
- Rachel Upjohn Building, East Medical Campus — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.